-
Indian scientists working on effective vaccines against COVID-19 and HIV: IISC
expresspharma
November 11, 2020
The studies were published in the Journal of Biological Chemistry and the Proceedings of the National Academy of Sciences.
-
Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
prnasia
November 10, 2020
The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. A Basel-based subsidiary, RocketVax AG, was founded to utilize innovative Swiss technologies and expertise to achieve this goal.
-
Scientists develop COVID-19 vaccine candidate that generates very high neutralising antibodies
expresspharma
November 06, 2020
The study finds that the nanoparticle vaccine generates ten times more protective antibodies in mice, even at a six-fold lower vaccine dose, and also shows a strong B-cell immune response after administration.
-
NPPA fixes retail price of new-gen rabies vaccine from Cadila Pharma at Rs 681.44
expresspharma
November 05, 2020
The company has not yet disclosed the official launch of the three-dose vaccine.
-
UK regulator initiates rolling review of AstraZeneca’s vaccine for Covid-19
pharmaceutical-technology
November 04, 2020
UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has initiated the accelerated rolling review of AstraZeneca’s potential vaccine to treat Covid-19.
-
DOD Awards Ology Vaccine Manufacturing Contract
contractpharma
October 29, 2020
CDMO to manufacture and test novel live attenuated tularemia vaccine candidate.
-
COVID-19 containment shaped by strength, duration of natural, vaccine-induced immunity
worldpharmanews
October 28, 2020
"Much of the discussion so far related to the future trajectory of COVID-19 has rightly been focused on the effects of seasonality and non-pharmaceutical interventions [NPIs], such as mask-wearing and physical distancing," said co-first author ...
-
Peru refuses Covid-19 vaccine purchase deal with AstraZeneca
pharmaceutical-technology
October 26, 2020
The Peruvian government has refused to sign an agreement with AstraZeneca to purchase coronavirus vaccine as the latter failed to provide sufficient data from its studies.
-
Envirotainer Adds 57% more RAP e2 capacity in the US
prnasia
October 22, 2020
Envirotainer, the global market leader and by far largest provider of temperature-controlled air freight solutions for pharmaceuticals, announced that they are increasing their RAP e2 network capacity in the US by 57%.
-
UK to establish human challenge studies for COVID-19 vaccines
europeanpharmaceuticalreview
October 22, 2020
The UK government hopes to expedite the development of a COVID-19 vaccine by investing £33.6 million in the first phase of establishing human challenge trials.